Abstract
RNA interference has tremendously advanced our understanding of gene function but recent reports have exposed undesirable side-effects. Recombinant Camelid single-domain antibodies (VHHs) provide an attractive means for studying protein function without affecting gene expression. We raised VHHs against gelsolin (GsnVHHs), a multifunctional actin-binding protein that controls cellular actin organization and migration. GsnVHH-induced delocalization of gelsolin to mitochondria or the nucleus in mammalian cells reveals distinct subpopulations including free gelsolin and actin-bound gelsolin complexes. GsnVHH 13 specifically recognizes Ca2+-activated gelsolin (K d ~10 nM) while GsnVHH 11 binds gelsolin irrespective of Ca2+ (K d ~5 nM) but completely blocks its interaction with G-actin. Both GsnVHHs trace gelsolin in membrane ruffles of EGF-stimulated MCF-7 cells and delay cell migration without affecting F-actin severing/cap** or actin nucleation activities by gelsolin. We conclude that VHHs represent a potent way of blocking structural proteins and that actin nucleation by gelsolin is more complex than previously anticipated.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00018-010-0266-1/MediaObjects/18_2010_266_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00018-010-0266-1/MediaObjects/18_2010_266_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00018-010-0266-1/MediaObjects/18_2010_266_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00018-010-0266-1/MediaObjects/18_2010_266_Fig4_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00018-010-0266-1/MediaObjects/18_2010_266_Fig5_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00018-010-0266-1/MediaObjects/18_2010_266_Fig6_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00018-010-0266-1/MediaObjects/18_2010_266_Fig7_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00018-010-0266-1/MediaObjects/18_2010_266_Fig8_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00018-010-0266-1/MediaObjects/18_2010_266_Fig9_HTML.gif)
Similar content being viewed by others
References
Le Clainche C, Carlier MF (2008) Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev 88:489–513
Kamioka H, Sugawara Y, Honjo T, Yamashiro T, Takano-Yamamoto T (2004) Terminal differentiation of osteoblasts to osteocytes is accompanied by dramatic changes in the distribution of actin-binding proteins. J Bone Miner Res 19:471–478
Cunningham CC, Stossel TP, Kwiatkowski DJ (1991) Enhanced motility in NIH 3T3 fibroblasts that overexpress gelsolin. Science 251:1233–1236
De Corte V, Bruyneel E, Boucherie C, Mareel M, Vandekerckhove J, Gettemans J (2002) Gelsolin-induced epithelial cell invasion is dependent on Ras–Rac signaling. EMBO J 21:6781–6790
Thompson CC, Ashcroft FJ, Patel S, Saraga G, Vimalachandran D, Prime W, Campbell F, Dodson A, Jenkins RE, Lemoine, Crnogorac-Jurcevic T, Yin HL, Costello E (2007) Pancreatic cancer cells overexpress gelsolin family-cap** proteins, which contribute to their cell motility. Gut 56:95–106
Azuma T, Witke W, Stossel TP, Hartwig JH, Kwiatkowski DJ (1998) Gelsolin is a downstream effector of rac for fibroblast motility. EMBO J 17:1362–1370
Gettemans J, Van Impe K, Delanote V, Hubert T, Vandekerckhove J, De Corte V (2005) Nuclear actin-binding proteins as modulators of gene transcription. Traffic 6:847–857
Ji L, Chauhan A, Wegiel J, Essa MM, Chauhan V (2009) Gelsolin is proteolytically cleaved in the brains of individuals with Alzheimer’s disease. J Alzheimers Dis 18:105–111
Li GH, Shi Y, Chen Y, Sun M, Sader S, Maekawa Y, Arab S, Dawood F, Chen M, De Couto G, Liu Y, Fukuoka M, Yang S, Da Shi M, Kirshenbaum LA, McCulloh CA, Liu P (2009) Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis. Circ Res 104:896–904
Nishio R, Matsumori A (2009) Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling. Circ Res 104:829–831
Page LJ, Suk JY, Huff ME, Lim HJ, Venable J, Yates J, Kelly JW, Balch WE (2005) Metalloendoprotease cleavage triggers gelsolin amyloidogenesis. EMBO J 24:4124–4132
Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N, Hamers R (1993) Naturally occurring antibodies devoid of light chains. Nature 363:446–448
Sheriff S, Constantine KL (1996) Redefining the minimal antigen-binding fragment. Nat Struct Biol 3:733–736
Muyldermans S, Baral TN, Retamozzo VC, De Baetselier P, De Genst E, Kinne J, Leonhardt H, Magez S, Nguyen VK, Revets H, Rothbauer U, Stijlemans B, Tillib S, Wernery U, Wyns L, Hassanzadeh-Ghassabeh G, Saerens D (2009) Camelid immunoglobulins and nanobody technology. Vet Immunol Immunopathol 128:178–183
Davies J, Riechmann L (1996) Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability. Protein Eng 9:531–537
Arbabi Ghahroudi M, Desmyter A, Wyns L, Hamers R, Muyldermans S (1997) Selection and identification of single-domain antibody fragments from camel heavy-chain antibodies. FEBS Lett 414:521–526
Conrath KE, Lauwereys M, Galleni M, Matagne A, Frere JM, Kinne J, Wyns L, Muyldermans S (2001) Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob Agents Chemother 45:2807–2812
De Genst E, Silence K, Decanniere K, Conrath K, Loris R, Kinne J, Muyldermans S, Wyns L (2006) Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc Natl Acad Sci USA 103:4586–4591
Decanniere K, Desmyter A, Lauwereys M, Ghahroudi MA, Muyldermans S, Wyns L (1999) A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops. Structure 7:361–370
Desmyter A, Transue TR, Ghahroudi MA, Thi MH, Poortmans F, Hamers R, Muyldermans S, Wyns L (1996) Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme. Nat Struct Biol 3:803–811
Gueorguieva D, Li S, Walsh N, Mukerji A, Tanha J, Pandey S (2006) Identification of single-domain, Bax-specific intrabodies that confer resistance to mammalian cells against oxidative-stress-induced apoptosis. FASEB J 20:2636–2638
Rothbauer U, Zolghadr K, Tillib S, Nowak D, Schermelleh L, Gahl A, Backmann N, Conrath K, Muyldermans S, Cardoso MC, Leonhardt H (2006) Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat Methods 3:887–889
Visintin M, Melchionna T, Cannistraci I, Cattaneo A (2008) In vivo selection of intrabodies specifically targeting protein–protein interactions: a general platform for an “undruggable” class of disease targets. J Biotechnol 135:1–15
Khan AA, Betel D, Miller ML, Sander C, Leslie CS, Marks DS (2009) Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat Biotechnol 27:549–555
Cao T, Heng BC (2005) Intracellular antibodies (intrabodies) versus RNA interference for therapeutic applications. Ann Clin Lab Sci 35:227–229
Persengiev SP, Zhu X, Green MR (2004) Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10:12–18
McBride HM, Millar DG, Li JM, Shore GC (1992) A signal-anchor sequence selective for the mitochondrial outer membrane. J Cell Biol 119:1451–1457
Meerschaert K, De Corte V, De Ville Y, Vandekerckhove J, Gettemans J (1998) Gelsolin and functionally similar actin-binding proteins are regulated by lysophosphatidic acid. EMBO J 17:5923–5932
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354
Detmers P, Weber A, Elzinga M, Stephens RE (1981) 7-Chloro-4-nitrobenzeno-2-oxa-1, 3-diazole actin as a probe for actin polymerization. J Biol Chem 256:99–105
Borek D, Minor W, Otwinowski Z (2003) Measurement errors and their consequences in protein crystallography. Acta Crystallogr D Biol Crystallogr 59:2031–2038
The CCP4 suite (1994) Programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50:760–763
Cowtan KD, Main P (1993) Improvement of macromolecular electron-density maps by the simultaneous application of real and reciprocal space constraints. Acta Crystallogr D Biol Crystallogr 49:148–157
Perrakis A, Harkiolaki M, Wilson KS, Lamzin VS (2001) ARP/wARP and molecular replacement. Acta Crystallogr D Biol Crystallogr 57:1445–1450
Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126–2132
Laskowski RA, Moss DS, Thornton JM (1993) Main-chain bond lengths and bond angles in protein structures. J Mol Biol 231:1049–1067
Hooft RW, Vriend G, Sander C, Abola EE (1996) Errors in protein structures. Nature 381:272
Chaponnier C, Yin HL, Stossel TP (1987) Reversibility of gelsolin/actin interaction in macrophages. Evidence of Ca2 + -dependent and Ca2 + -independent pathways. J Exp Med 165:97–106
Bryan J, Kurth MC (1984) Actin–gelsolin interactions. Evidence for two actin-binding sites. J Biol Chem 259:7480–7487
van de Wijngaart DJ, van Royen ME, Hersmus R, Pike AC, Houtsmuller AB, Jenster G, Trapman J, Dubbink HJ (2006) Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain. J Biol Chem 281:19407–19416
Nishimura K, Ting HJ, Harada Y, Tokizane T, Nonomura N, Kang HY, Chang HC, Yeh S, Miyamoto H, Shin M, Aozasa K, Okuyama A, Chang C (2003) Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Res 63:4888–4894
Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin HL, Hayoz D (2004) Gelsolin superfamily proteins: key regulators of cellular functions. Cell Mol Life Sci 61:2614–2623
Van den Abbeele A, De Corte V, Van Impe K, Bruyneel E, Boucherie C, Bracke M, Vandekerckhove J, Gettemans J (2007) Downregulation of gelsolin family proteins counteracts cancer cell invasion in vitro. Cancer Lett 255:57–70
Burtnick LD, Koepf EK, Grimes J, Jones EY, Stuart DI, McLaughlin PJ, Robinson RC (1997) The crystal structure of plasma gelsolin: implications for actin severing, cap**, and nucleation. Cell 90:661–670
Korotkov KV, Pardon E, Steyaert J, Hol WG (2009) Crystal structure of the N-terminal domain of the secretin GspD from ETEC determined with the assistance of a nanobody. Structure 17:255–265
Lam AY, Pardon E, Korotkov KV, Hol WG, Steyaert J (2009) Nanobody-aided structure determination of the EpsI:EpsJ pseudopilin heterodimer from Vibrio vulnificus. J Struct Biol 166:8–15
Baldassare JJ, Henderson PA, Tarver A, Fisher GJ (1997) Thrombin activation of human platelets dissociates a complex containing gelsolin and actin from phosphatidylinositide-specific phospholipase Cgamma1. Biochem J 324(Pt 1):283–287
Dadabay CY, Patton E, Cooper JA, Pike LJ (1991) Lack of correlation between changes in polyphosphoinositide levels and actin/gelsolin complexes in A431 cells treated with epidermal growth factor. J Cell Biol 112:1151–1156
Way M, Pope B, Weeds AG (1992) Are the conserved sequences in segment 1 of gelsolin important for binding actin? J Cell Biol 116:1135–1143
Heidemann SR, Kaech S, Buxbaum RE, Matus A (1999) Direct observations of the mechanical behaviors of the cytoskeleton in living fibroblasts. J Cell Biol 145:109–122
Witke W, Li W, Kwiatkowski DJ, Southwick FS (2001) Comparisons of CapG and gelsolin-null macrophages: demonstration of a unique role for CapG in receptor-mediated ruffling, phagocytosis, and vesicle rocketing. J Cell Biol 154:775–784
West MA, Antoniou AN, Prescott AR, Azuma T, Kwiatkowski DJ, Watts C (1999) Membrane ruffling, macropinocytosis and antigen presentation in the absence of gelsolin in murine dendritic cells. Eur J Immunol 29:3450–3455
Cooper JA, Bryan J, Schwab B 3rd, Frieden C, Loftus DJ, Elson EL (1987) Microinjection of gelsolin into living cells. J Cell Biol 104:491–501
Nag S, Ma Q, Wang H, Chumnarnsilpa S, Lee WL, Larsson M, Kannan B, Hernandez-Valladares M, Burtnick LD, Robinson RC (2009) Ca2 + binding by domain 2 plays a critical role in the activation and stabilization of gelsolin. Proc Natl Acad Sci USA 106:13713–13718
Way M, Gooch J, Pope B, Weeds AG (1989) Expression of human plasma gelsolin in Escherichia coli and dissection of actin-binding sites by segmental deletion mutagenesis. J Cell Biol 109:593–605
Burtnick LD, Urosev D, Irobi E, Narayan K, Robinson RC (2004) Structure of the N-terminal half of gelsolin bound to actin: roles in severing, apoptosis and FAF. EMBO J 23:2713–2722
Sagot I, Rodal AA, Moseley J, Goode BL, Pellman D (2002) An actin nucleation mechanism mediated by Bni1 and profilin. Nat Cell Biol 4:626–631
Pope B, Way M, Weeds AG (1991) Two of the three actin-binding domains of gelsolin bind to the same subdomain of actin. Implications of cap** and severing mechanisms. FEBS Lett 280:70–74
Kwiatkowski DJ, Janmey PA, Yin HL (1989) Identification of critical functional and regulatory domains in gelsolin. J Cell Biol 108:1717–1726
Robinson RC, Mejillano M, Le VP, Burtnick LD, Yin HL, Choe S (1999) Domain movement in gelsolin: a calcium-activated switch. Science 286:1939–1942
Choe H, Burtnick LD, Mejillano M, Yin HL, Robinson RC, Choe S (2002) The calcium activation of gelsolin: insights from the 3A structure of the G4–G6/actin complex. J Mol Biol 324:691–702
Bryan J, Hwo S (1986) Definition of an N-terminal actin-binding domain and a C-terminal Ca2 + regulatory domain in human brevin. J Cell Biol 102:1439–1446
Kwiatkowski DJ, Janmey PA, Mole JE, Yin HL (1985) Isolation and properties of two actin-binding domains in gelsolin. J Biol Chem 260:15232–15238
Ditsch A, Wegner A (1994) Nucleation of actin polymerization by gelsolin. Eur J Biochem 224:223–227
Hesterkamp T, Weeds AG, Mannherz HG (1993) The actin monomers in the ternary gelsolin: 2 actin complex are in an antiparallel orientation. Eur J Biochem 218:507–513
Doi Y (1992) Interaction of gelsolin with covalently cross-linked actin dimer. Biochemistry 31:10061–10069
Wille M, Just I, Wegner A, Aktories K (1992) ADP-ribosylation of gelsolin–actin complexes by clostridial toxins. J Biol Chem 267:50–55
Roustan C, Lagarrigue E, Tement D, Maciver SK, Fattoum A, Benyamin Y (2006) Evidence for anti-parallel actin dimer formation by calcium-activated gelsolin and its role in the nucleation of actin assembly. Calc Bind Prot 1:45–50
Nolen BJ, Tomasevic N, Russell A, Pierce DW, Jia Z, McCormick CD, Hartman J, Sakowicz R, Pollard TD (2009) Characterization of two classes of small molecule inhibitors of Arp2/3 complex. Nature 460:1031–1034
Acknowledgments
We thank Evelien Martens for technical support. This work was supported by the Fund for Scientific Research-Flanders (FWO-Vlaanderen), the Stichting tegen Kanker, the Vlaamse Liga tegen Kanker, the Concerted Actions Program of Ghent University (GOA), the Interuniversity attraction poles (IUAP06) and the VIB. AVdA is supported by the Vlaamse Liga tegen Kanker through a grant of the Stichting Emmanuel van der Schueren.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Van den Abbeele, A., De Clercq, S., De Ganck, A. et al. A llama-derived gelsolin single-domain antibody blocks gelsolin–G-actin interaction. Cell. Mol. Life Sci. 67, 1519–1535 (2010). https://doi.org/10.1007/s00018-010-0266-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-010-0266-1